Evidence map›Paper›PMID 26235895›Full record

ArticleStem cell reports2015

Podocyte Regeneration Driven by Renal Progenitors Determines Glomerular Disease Remission and Can Be Pharmacologically Enhanced.

Laura Lasagni, Maria Lucia Angelotti, Elisa Ronconi, Duccio Lombardi, Sara Nardi, Anna Peired, Francesca Becherucci, Benedetta Mazzinghi, Alessandro Sisti, Simone Romoli and 5 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. The Life of a Kidney Podocyte.Acta physiologica (Oxford, England) · 2025
    Review
  7. Article
  8. Piezo1, F-Actin Remodeling, and Podocyte Survival and Regeneration.Journal of the American Society of Nephrology : JASN · 2025
    Article
  9. Review
  10. Podocytes in health and glomerular disease.Frontiers in cell and developmental biology · 2025
    Review
  11. Article
  12. Mice with aAmerican journal of physiology. Renal physiology · 2024
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Laura LasagniExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. Electronic address: laura.lasagni@unifi.it.
Maria Lucia AngelottiExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Elisa RonconiExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy; Department of Clinical and Experimental Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Duccio LombardiExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Sara NardiNephrology Unit, Meyer Children's University Hospital, Viale Pieraccini 24, 50141 Florence, Italy.
Anna PeiredExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy; Department of Clinical and Experimental Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
Francesca BecherucciNephrology Unit, Meyer Children's University Hospital, Viale Pieraccini 24, 50141 Florence, Italy.
Benedetta MazzinghiNephrology Unit, Meyer Children's University Hospital, Viale Pieraccini 24, 50141 Florence, Italy.
Alessandro SistiExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Simone RomoliExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Alexa BurgerInstitute of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 190, 8057 Zürich, Switzerland.
Beat SchaeferDepartment of Oncology and Children's Research Center, University Children's Hospital, Steinwiesenstrasse 75, 8032 Zurich, Switzerland.
Annamaria BuccolieroPathology Unit, Meyer Children's Hospital, Viale Pieraccini 24, 50141 Florence, Italy.
Elena LazzeriExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Paola RomagnaniExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy; Department of Clinical and Experimental Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy; Nephrology Unit, Meyer Children's University Hospital, Viale Pieraccini 24, 50141 Florence, Italy. Electronic address: paola.romagnani@unifi.it.
University of Florence · ITMeyer Children's Hospital · ITUniversity Children's Hospital Zurich · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Podocyte loss is a general mechanism of glomerular dysfunction that initiates and drives the progression of chronic kidney disease, which affects 10% of the world population. Here, we evaluate whether the regenerative response to podocyte injury influences chronic kidney disease outcome. In models of focal segmental glomerulosclerosis performed in inducible transgenic mice where podocytes are tagged, remission or progression of disease was determined by the amount of regenerated podocytes. When the same model was established in inducible transgenic mice where renal progenitors are tagged, the disease remitted if renal progenitors successfully differentiated into podocytes, while it persisted if differentiation was ineffective, resulting in glomerulosclerosis. Treatment with BIO, a GSK3s inhibitor, significantly increased disease remission by enhancing renal progenitor sensitivity to the differentiation effect of endogenous retinoic acid. These results establish renal progenitors as critical determinants of glomerular disease outcome and a pharmacological enhancement of their differentiation as a possible therapeutic strategy.

Indexed as

Cell DifferentiationRegenerationAnimalsCells, CulturedGlycogen Synthase Kinase 3IndolesMiceMice, Inbred C57BLOximesPodocytesRenal Insufficiency, ChronicStem Cells6-bromoindirubin-3'-oximeGlycogen Synthase Kinase 3IndolesOximes

Identifiers

PMID26235895
PMCPMC4618832
OpenAlexW1677887083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.